Skip to content
Back to events

GW4 AMR Alliance Launch Event

GW4 AMR Alliance Launch Event

The GW4 AMR Alliance online launch event – ‘GW4 AMR Alliance: Our Interdisciplinary Approach to One Health AMR’ is taking place on Wednesday 16 June 2021 (13:30-17:00). It will comprise a showcase of our One Health AMR research with Q&A and roundtable discussion sessions.

To register, please go to the Eventbrite site

Agenda

Welcome and introduction – ‘The GW4 AMR Alliance’ – Prof Jonathan Knight (University of Bath and Chair of the GW4 Board)

Session 1 – Keynote presentation by Dr Timothy Jinks (Head, Drug-Resistant Infections Programme, Wellcome Trust)

Session 2 – ‘What are drivers of AMR in the One Health Domain?’ (Moderated by Dr Susanne Gebhard, University of Bath)

Short talks by:

  • Prof Matthew Avison (Bristol) ‘One Health Drivers of AMR: lessons from research in the UK and Thailand’
  • Prof Helen Lambert (Bristol) ‘Social and cultural drivers and strategies to reduce the burden of antimicrobial resistance’
  • Prof William Gaze (Exeter) ‘The environmental dimensions of AMR’
  • Prof Jean-Yves Maillard (Cardiff) Biocides: Emergence of microbial resistance and cross-resistance to antimicrobial in the One Health context’
  • Prof Ed Feil (Bath) ‘Gauging the risk from environmental reservoirs of AMR’
  • Prof Stephen Hinchliffe (Exeter) ‘Changing agriculture: Social and economic drivers of disease and treatment decisions in food production settings’
  • Dr Kristen Reyher (Bristol) ‘Veterinary medicine use and One Health AMR – known unknowns’

Q&A and roundtable discussion on future implications for modifying the drivers of AMR (Chaired by Dr Tim Jinks)

Session 3 – The challenge of antimicrobial resistant pathogens in the real world and potential interventions

Short talks by:

  • Dr Maisem Laabei (Bath) ‘A new GW4 early career AMR community to develop leads to treat multi-resistant pathogens’
  • Prof Adilia Warris (MRC Centre for Medical Mycology, Exeter) ‘Challenges of antifungal resistance in clinical practice’
  • Prof Eshwar Mahenthiralingam (Cardiff) ‘AMR lung infections in people with cystic fibrosis and antibiotic treatment failure’

Q&A and roundtable discussion on the next big questions in One Health and the agenda going forwards'(Chaired by Prof Matthew Avison)

Closing remarks – Prof Philip Taylor (University of Bristol and GW4 Board)

University of Bath
University of Bristol
Cardiff University
University of Exeter